SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories informs about newspaper publication

11 Feb 2026 Evaluate
Pursuant to Regulation 30 under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Makers Laboratories has enclosed copies of the Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2025 published on 11th February, 2026 in Business Standard (all India editions) and Nav Shakti (in Marathi).

The above information is a part of company’s filings submitted to BSE. 

Makers Laboratories Share Price

160.15 2.40 (1.52%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×